Abstract
COVID-19 pandemic has given rise to a collective scientific effort to study its viral causing agent SARS-CoV-2. Research is focusing in particular on its infection mechanisms and on the associated-disease symptoms. Interestingly, this environmental pathogen directly affects the human chemosensory systems leading to anosmia and ageusia. Evidence for the presence of the cellular entry sites of the virus, the ACE2/TMPRSS2 proteins, has been reported in non-chemosensory cells in the rodent’s nose and mouth, missing a direct correlation between the symptoms reported in patients and the observed direct viral infection in human sensory cells. Here, mapping the gene and protein expression of ACE2/TMPRSS2 in the mouse olfactory and gustatory cells, we precisely identify the virus target cells to be of basal and sensory origin and reveal the age-dependent appearance of viral entry-sites. Our results propose an alternative interpretation of the human viral-induced sensory symptoms and give investigative perspectives on animal models.
Similar content being viewed by others
Introduction
The Corona Virus Disease 2019 (COVID-19) has federated worldwide scientific efforts for understanding the viral epidemiological mechanisms of the coronavirus 2 (SARS-CoV-2) that causes this severe acute respiratory syndrome. In humans, the viral syndrome is characterized by an increased mortality rate in aged and/or comorbidity patients associated with the upper respiratory infection symptoms, such as severe respiratory distress1,2,3. In addition to its major impact, COVID-19 is associated by its direct alteration of human olfaction and gustation, in absence of substantial nasal inflammation or coryzal signs, resulting to anosmia and ageusia in up to 77% of the patients4,5,6,7. While these sensory symptoms are well established and intensely affect everyday behaviors8,9, the precise related mechanisms remain elusive10.
The target cells of the virus share a molecular signature: the concomitant cellular expression of the angiotensin-converting enzyme 2 (ACE2) and of its facilitating transmembrane serine protease 2 (TMPRSS2), which plays a crucial role for the interaction of viral spike proteins with the host cell11,12,13. Paradoxically, these entry sites seem to be lacking in sensory cells14,15,16,17,18, while a direct SARS-CoV-2 contamination has been observed both in humans and rodents19,20, requesting further investigations to explain the sensory-associated symptoms21,22,23,24. Therefore, the characterization of the animal model is necessary prior to its use to understand the causality underling the viral-induced sensory symptoms.
The use of mice is indeed limited for epidemiological studies due to their absence of hands, which, with aerosols, are the foremost passages of interindividual viral transmission25, as well as their published lack of SARS-CoV-2 ACE2-spike protein affinity26,27. Nevertheless, the ease of production of genetically modified mice and their scientific availability, as well as their well-studied and specialized chemosensory systems28,29,30, make them a valuable ally for the development of potential prophylactic and protective treatments related to these sensory symptoms.
Thus, we aimed here at characterizing the potential viral entry sites across mouse sensory systems. We found SARS-CoV-2 entry cells to be of different origins depending on the sensory systems. In summary, the virus could target cells involved in tissue regulation such as the supporting cells of the olfactory receptor neurons and the regenerative basal cells but also, specifically, the chemosensory cells of both gustatory and olfactory systems. We finally revealed that the emergence of viral entry sites in sensory and basal cells only occurs with age, which could explain both, the observed COVID-19 long-lasting effects and the age-dependent sensory-symptomatology in human.
Results
SARS-CoV-2 entry genes are differentially expressed in the mouse sensory systems
Focusing on the mouse, where chemosensing takes place in different sensory systems (Fig. 1a), we took advantage of our previous studies31,32,33,34,35 to first assess their overall expression of the major SARS-CoV-2 entry sites. Interestingly, we found a differential expression of the Ace2 and Tmprss2 transcripts (Fig. 1b, c and Supplementary Fig. 1). Ace2 is strongly expressed in a specific area of the main olfactory epithelium (MOE), the dorsal part (MOED) which is directly exposed to the environment and specialized in sensing volatile chemical cues14,15. Moreover, we observed a previously unreported expression of Ace2, in the most rostral sensory subsystem, the Grueneberg ganglion (GG), mostly implicated in volatile danger cues detection34,35,36 as well as in the different taste papillae, the fungiform (Fu), the foliate (Fo) and the circumvallate (CV) taste papillae, all involved in water-soluble tastant perception29. Interestingly, this specific pattern of Ace2 expression seems to be correlated with the mode of viral dissemination (volatile suspensions of viral droplets25), as only a limited expression of Ace2 is found in the vomeronasal organ (VNO) and in the septal organ of Masera (SO), considered to be implicated in pheromonal and retronasal communications via indirect and only limited access to the environment30. Concerning the associated facilitating cleavage protease, we found that the Tmprss2 transcript was expressed in all olfactory subsystems and to a limited extent at the taste Fu, Fo and CV level (Fig. 1b, c and Supplementary Fig. 1). Thus, this apparent disparity of expression requires further investigations to identify the precise cells expressing these entry sites in the different mouse subsystems.
SARS-CoV-2 entry cells in the MOED are of non-neuronal and multipotent types
Taking advantage of a genetically modified mouse model in which, the olfactory marker protein37 (OMP) drives the expression of the green fluorescent protein (GFP) in all mature olfactory neurons38,39, we first examined the MOED sensory epithelium (Fig. 2) which is continuously exposed to inhaled air (Fig. 2a). Remarkably, we found by immunohistochemical stainings that the ACE2 protein was not only expressed at the apical surface and in the Bowman’s glands14,15,16,21 but also in the basal layer (Fig. 2b). Moreover, we found that, in addition to being irregularly localized in different regions of the neuroepithelium15 (Supplementary Fig. 2a), TMPRSS2 was mostly co-expressed with ACE2 in these OMP-negative basal cells (Fig. 2c, d). Focusing on the identification of these ACE2-expressing cells (Fig. 3), we first confirmed that the cytokeratin 18 (CK18)-positive sustentacular cells16,21, operating as supporting cells for the olfactory neurons, were indeed harboring, at their luminal surface, the observed ACE2 protein (Fig. 3a). Moreover, we found ACE2 apical expression to be localized below the olfactory sensory cilia expressing the cyclic nucleotide-gated channel alpha 2 subunits (CNGA2; Supplementary Fig. 2b), supporting its previously reported sustentacular microvilli affiliation14,15. We next established the multipotency characteristics of the ACE2-expressing basal cells, as they also expressed two proteins specific to their identity of stem cells, the perinuclear cytokeratin 5 (CK5; Fig. 3b) and, predominantly, the nuclear transcription factor sex determining region Y-box 2 (SOX2; Fig. 3c), markers of horizontal basal cells (HBCs) or of the pear-shaped globose basal cells (GBCs) respectively. These two populations of basal cells are both involved in the regeneration of the neuroepithelium by acting as short- and long-lasting reservoir cells14,40,41. Taken together, we confirmed our initial RT-PCR and qRT-PCR results (Fig. 1b, c) by precisely profiling the ACE2 and TMPRSS2 expression in the MOED neuroepithelium. We found that the cell candidates for viral entry are ACE2-expressing cells of non-neuronal and multipotent origin.
SARS-CoV-2 entry cells in taste papillae are mature sensory cells
Wondering about the apparent limited level of Tmprss2 transcript in the different taste papillae (Fig. 1b, c), we next decided to exploit our histological methodology (Figs. 2, 3) to precisely localize the potential SARS-CoV-2 entry sites in sensory cells of the Fu, Fo and CV taste buds (Fig. 4 and Supplementary Figs. 3 and 4). For that, we first used Gα gustucin (GUST) as a marker of sensory cells in the tongue32, to identify taste buds in close contact with the oral cavity (Fig. 4a, Supplementary Figs. 3a and 4a). Surprisingly, using a double immunostaining approach, we distinctly observed ACE2 expression, not only in apical keratinocytes17,42, but also in sensory cells (Fig. 4b, Supplementary Figs. 3a and 4a). Moreover, ACE2 is predominantly expressed in the microvilli of sensory cells, gathered in the so-called taste pore, which are directly exposed to substances entering the oral cavity29, such as viral droplets (Fig. 4b, Supplementary Figs. 3a and 4a). Furthermore, we observed a restricted localization of TMPRSS2 in the taste pore region, strikingly co-expressed with ACE2 (Fig. 4c, d, Supplementary Figs. 3b and 4b) which might also explain the observed low-level signal for the Tmprss2 transcript (Fig. 1b, c). We next confirmed the mature status of these ACE2-expressing sensory cells as they preferentially expressed the CK18 marker43 (Fig. 5a). Moreover, and contrary to the MOED, we found only sporadic ACE2 expression in basal CK5-positive cells (Fig. 5b) and SOX2-positive cells (Fig. 5c, d). In summary, we identified here the co-expression of the main SARS-CoV-2 entry sites in mature taste sensory cells.
SARS-CoV-2 entry cells in the GG are sensory neurons
In the mouse, there is an ancestral sensory subsystem, the GG (Fig. 6), which has the particularity of displaying both olfactory and gustatory traits31,32,44. Morphologically, GG neurons are covered with a keratinized epithelium permeable to volatile water-soluble molecules coming from the nasal cavity35 (Fig. 6a). Molecularly, it expresses both main sensory markers, OMP and GUST32 and uses common sensory signals such as olfactory and taste receptors32 to respond to both danger-associated odorants and tastants32,35,36. Performing histological approaches, we first noticed that the apical keratinocyte cell layer was, as in the different taste papillae, positive for ACE2 expression (Fig. 6b). But more surprising, we next found ACE2 expression in the GG cells (Fig. 6b). Interestingly and contrary to the MOED, this expression was distinctly restricted to the sensory GG neurons and not found in the supporting S100 calcium-binding protein β (S100B)-expressing glial cells35 (Supplementary Fig. 5a). Remarkably, we furthermore localized TMPRSS2 both in apical keratinocytes and in GG neurons indicating that the two main SARS-CoV-2 entry sites are indeed found in the GG sensory subsystem (Fig. 6c, d). Looking for a precise characterization of ACE2-expressing cells in the GG, we next discovered that OMP-positive GG neurons were also CK18-positive (Fig. 7a) giving the GG a double cellular affiliation (neuronal and fibroblastic) that also highlights the discovery of CK18 as a reliable marker of ACE2-expressing cells, the putative target cells of viral infection45. We next observed that in the apical keratinocyte layer of the GG, ACE2-expressing cells are mostly mature as they rarely co-expressed CK5 and SOX2 (Supplementary Fig. 5b, c), a characteristic shared with taste tissue (Fig. 5). Interestingly, and as previously shown, no regeneration happened throughout the lifespan in the GG subsystem31,46 as basal cells are absent which was further confirmed here by a lack of SOX2 staining (Supplementary Fig. 5c). However, we observed in GG neurons, a punctiform-like staining for ACE2 and CK5 (Supplementary Fig. 5b) indicating a co-expression in a precise cytoskeleton structure, as for the taste buds (Fig. 4b, Supplementary Figs. 3a and 4a). We found that these cytoskeleton regions were associated to GG primary cilia (Fig. 7b, c), an organelle implicated in chemosensing33,36. Thanks to the particulate guanylyl cyclase G (pGCG; Fig. 7b), a marker of the axonemes of the GG-cilia33, we observed that ACE2 was located in the so-called basal body structures (Fig. 7c), where it was also co-expressed with the gamma-tubulin marker35 (γ-TUB; Fig. 7c). In summary, we found that the GG sensory subsystem possesses both the viral target cells and the specific protein profiles of expression displayed by both the olfactory and taste systems. Moreover, we bring here evidences of the presence of viral entry sites in a particular population of chemosensory cells, the olfactory GG neurons.
SARS-CoV-2 entry sites expression in mouse chemosensory systems is age-dependent
During the course of our experiments, we noticed interindividual variations of ACE2 expression not only in its intensity but also in its general arrangement (e.g., apical versus basal ACE2 expression in the MOED; (Fig. 2b, c). Moreover, this observation was not only done for the MOED (Figs. 2, 3), but also for the taste buds of the CV papillae (Figs. 4, 5) as well as for the GG (Figs. 6, 7). We considered a potential age-dependent correlation47,48,49,50 and thus we next challenged the expression of Ace2 and Tmprss2 transcripts through the different chemosensory subsystems using mice of chosen ages (Fig. 8 and Supplementary Fig. 6). Using both RT-PCR and qRT-PCR experiments, we confirmed our assumption at the RNA level as we observed and quantified a significant increase of both Ace2 and Tmprss2 transcripts with age in the MOED (Fig. 8a, d and Supplementary Fig. 6a, d), in the CV (Fig. 8b, e and Supplementary Fig. 6b, e) and in the GG (Fig. 8c, f and Supplementary Fig. 6c, f). As this age-dependence was particularly striking for Ace2, we next focused on its expression at the protein level (Fig. 9 and Supplementary Fig. 7). After a first validation of this age-dependent trend in a series of western-blot quantifications (Supplementary Fig. 7a–c), we subsequently undertook a precise immunohistochemical localizations of ACE2 expression in the different chemosensory subsystems (Fig. 9). Accordingly, we observed an intense variation of its expression in the MOED (Fig. 9a). Indeed, in young mice, this expression was restricted to the apical region, and then gradually intensifies with age (Fig. 9a). At the basal level, it appears to be absent first and only shows up in adult mice (Fig. 9a). Moreover, these variations were directly associated with an increase in ACE2 expression in existing cells. The sustentacular and basal cells are present at all ages of interest (Fig. 9b). In the sensory cells of the CV, ACE2 appears to be absent in young mice and only emerges with age (Fig. 9c). Interestingly, ACE2 expression initiates in the microvilli, at around 5 months of age, and then gradually extents throughout the cell body with aging (Fig. 9c). Concerning the GG, we first noticed that its apical keratinocyte cell layer constitutively expressed ACE2, while its expression was distinctly age-dependent in the sensory neurons (Fig. 9d). Indeed, and as for the sensory cells of the CV (Fig. 9c), a subcellular expression was first observed which spread into the soma with time (Fig. 9d). Overall, we demonstrated here a striking age-dependent increase of SARS-CoV-2 entry sites expression, in particular for ACE2 across mouse chemosensory systems.
Discussion
Our ability to perceive and interact with our environment is directly linked to our senses. From an evolutionary point of view, our sensory performance is often associated with the way we communicate with our surroundings. In humans, although olfaction and taste have lost importance in comparison with mice, they remain essential not only to our well-being but also to protect us from dangers such as intoxication10. Their disorders are correlated with our general and mental health and can be early indicators of central nervous system impairments51,52. Our sensory systems have developed a variety of protective mechanisms to guard us against environmental attacks such as the presence of protective keratinous epithelia, the combined action of mucus and cilia of sustentacular cells, ensuring the drainage of environmental microorganisms via mucociliary fluid clearance53 or even the presence of regenerative basal cells40,41. SARS-CoV-2 seems to have found a mechanism to thwart our sensory defenses. Indeed, we have shown here that, in mice, these very protective cells express viral entry sites. Although the direct action by the virus on these cells remains to be demonstrated, the underlying inflammatory22,24,54 or cytopathic destruction mechanisms23 would strongly impact the senses of smell and taste. It therefore seems obvious that their targeted impairment can directly contribute to long-term anosmia and ageusia7,55. Moreover, we have demonstrated here that the sensory cells themselves also express the SARS-CoV-2 entry sites which could contribute to both the sensory symptoms observed on the short term14,15,19,21 and the ability of coronaviruses to directly infect human sensory cells20.
From a clinical point of view, anosmia and ageusia have a low prevalence in infected children and increase with the age of the COVID-19 patient50,56, which seems to be consistent with the protein expression of ACE2 that we have observed in the mice olfactory system. Indeed, after we first confirmed the age-dependent trend made of ACE2 expression in sustentacular cells47, we focused on the dorsal part of the MOE and found that the basal cells of the neuronal epithelium also expressed ACE2 as a function of age. Interestingly, TMPRSS2 is also expressed in these SARS-CoV-2 target cells. However, further studies, using viral inoculation for example, are still necessary to link this specific protein expression with viral sensitivity. Moreover, we also observed this age-effect in the taste system. As an absence of expression of the viral entry sites is found in the sensory cells of young mice, but an increased expression of ACE2 and TMPRSS2 appears in sensory cells when the mouse advances in age. Thus, SARS-CoV-2 could therefore also directly target these sensory cells in aged mice expressing, for example, the human form of ACE2 (hACE2) under the mouse Ace2 promotor45,57 and, possibly, in aged humans42, altering them and consequently disabling the taste sensory ability leading to ageusia symptoms. Thus, the use of animal models such as mice sensitized to the virus45,57,58,59,60 or Syrian hamsters that are naturally compatible with SARS-CoV-2 infections19,21,61, appears to be a promising strategy but the age of the animals has to be carefully considered and older animals should preferentially be used (from 9 months of age for mice). To reinforce the importance of this notion, previous elegant single cell transcriptomic analysis indeed reported only limited expression of Ace2 in taste cells of young and embryonic mice17. We reported here a similar observation both at the RNA and protein levels in young mice and we completed this description by looking at ACE2 expression in aged mice. Thus, we found that the age of the animal directly impacts the interpretations of the results obtained in SARS-CoV-2 studies17,42,62. Interestingly, based on our results, additional studies performed on the lower respiratory airways could show whether a similar increased ACE2 expression, as a function of age occurs not only in respiratory ciliated cells49,63 but also in basal cells which could therefore contribute, in association with other factors such as interferon-stimulation64,65, to the differences in pulmonary infectiousness observed between young and older people66.
Mice possess multiple sensory systems, separated into specialized subsystems30, that we have now precisely characterized for their expression of the viral entry proteins. Interestingly, our study identified the GG to express the SARS-CoV-2 entry sites on its sensory neurons. We also found that GG sensory neurons expressed CK18, confirming that the cellular expression of this protein is an excellent marker for the localization of putative viral entry cells45. Moreover, this observation is remarkable and gives to the GG a double cellular affiliation, namely neuronal and fibroblastic by the expression of both OMP and CK18. In this period of race for collective immunity9, we desperately need animal models to study this disease. Our results not only confirm the unique primary origin of the GG44 but, also make it useful as a model of sensory systems to study, in ex-vivo and in-vivo preparations35 from hACE2 mouse or Syrian hamster33, the mechanism of viral entry into sensory cells as well as the testing of potential protective treatments against viral infection, such as intranasal drugs and/or COVID-19 vaccine candidate delivery13,67,68. Reinforcing this idea, it should be noted that another SARS-CoV-2 portal of entry, neuropilin-169,70 is also expressed in the GG71, thus increasing its infectious susceptibility.
In summary, we have precisely characterized the SARS-CoV-2 entry cells in the multiple sensory systems of the mouse. These cells are of different origins. They are either involved in tissue function and regeneration but also, specifically, in chemosensing. We have revealed that the expression of viral entry sites in sensory cells increases with age, in this experimental model, which might be an important factor for viral infectivity studies. Thus, we have suggested a direct correlation between human sensory-symptomatology and mice SARS-CoV-2-expressing entry cells providing a putative explanation for the observed anosmia and ageusia in COVID-19 patients.
Methods
Animals
C57BL/6 mice (Mus musculus; Janvier Labs) and heterozygous OMP-GFP mice39, of both sexes, were used at the indicated ages. In this gene-targeted mouse strain, mature olfactory sensory neurons37 expressed the histological reporter GFP under the control of the OMP promoter38,39. Mice were grouped-housed between 21 and 23 °C under a 12 h light/dark cycle with ad libitum access to food and water. Mice were euthanized by CO2 inhalation and the experimental procedures were in accordance with Swiss legislation and approved by the EXPANIM committee of the Lemanique Animal Facility Network and the veterinary authority of Canton de Vaud (SCAV).
Chemosensory epithelia isolation
Prior to tissue isolation processes, phosphate-buffered saline (PBS; 138 mM NaCl, 2.7 mM KCl, 1.76 mM KH2PO4, and 10 mM Na2HPO4, pH 7.4), dissection tools and equipment were sterilized and RNase removing agent (RNaseZAPTM; Sigma) treatments were applied. The chemosensory epithelia were localized under the fluorescent stereomicroscope (M165 FC; Leica) thanks to the GFP expression for the olfactory subsystems32,33. The dorsal GFP-positive prolongation of the main olfactory epithelium (MOED), corresponding to the ethmoid turbinate 1E adherent to the nasal bone, was separated from the rest of the MOE for the analysis. The other olfactory subsystems, the VNO, the SO and the GG were delicately separated from the neighboring GFP negative tissues. The Fu, the Fo, and the CV papillae were extracted from the surface of the tongue.
Gene expression profile by RT-PCR and qRT-PCR
RNA purification was completed according to the instructions of the manufactured kit (RNeasy® Plus Mini kit; Qiagen). Briefly, the chemosensory epithelia obtained from 5 to 10 mice (with a comparable sex ratio) were isolated and pooled in buffer RLT Plus supplemented with b-mercaptoethanol. Homogenization was performed through high-speed tissue disruption (TissueLyser II; Qiagen) and genomic DNA was removed from lysate by using the gDNA Eliminator spin column. Centrifugation and loaded processes were performed onto RNeasy spin columns to finally elute the total RNA in 30 μl of RNase-free water. Reverse transcription (RT) was then initiated with the cDNA synthesis kit (PrimeScriptTM 1st strand cDNA Synthesis Kit; Takara) using 140 ng of RNA and the random hexamers option to obtain a final volume of 20 μl of cDNA.
RT-PCR investigations
For reverse transcription polymerase chain reaction (RT-PCR), PCR experiments were subsequently performed using 3 μl of cDNA and 800 nM of each specific primers for Ace2 (forward 5′–CTACAGGCCCTTCAGCAAAG–3′; reverse 5′–TGCCCAGAGCCTAGAGTTGT–3′; product size of 204 bp), Tmprss2 (forward 5′-ACTGACCTCCTCATGCTGCT-3′; reverse 5′-TGACAGATGTTGAGGCTTGC-3′; product size of 225 bp) and Gapdh (forward 5′-AACTTTGGCATTGTGGAAGG-3′; reverse 5′-ACACATTGGGGGTAGGAACA-3′; product size of 223 bp). Primers were designed using the Primer3plus resource32. Amplification was done with 1.0 units of DNA Polymerase (GoTaq® DNA Polymera; Promega) using a thermocycler (Veriti™; Applied Biosystems) programmed at 95 °C 30 s, 55 °C 30 s, and 68 °C 45 s for 30 cycles. Visualization of the amplification products was done with ethidium bromide on a 3% electrophoresis gel and sizes were assessed (Bench Top 100 bp DNA Ladder; Promega). Negative controls were performed with H2O or by omitting the reverse transcription phase. The RT-PCR semi-quantitative analyses of Ace2 and Tmprss2 were calculated according to the intensities detected under the curves72 (ImageJ; 1.53a) relatively expressed to Gapdh.
qRT-PCR investigations
For quantitative RT-PCR (qRT-PCR), amplifications of Ace2 and Tmprss2, as well as Gapdh as housekeeping gene and H2O for internal control, were performed with a Real-Time PCR system detector (7500 Fast Real-Time PCR System; Applied Biosystems). All reactions were performed in duplicates with a final volume of 20 μl, containing 1× SYBR® Green enzyme (Fast SYBR Green Master Mix; Applied Biosystems), 800 nM of primers and 3 μl of cDNA and by using universal and fast PCR cycling conditions. A threshold line of 0.15 was applied to compare the different CT (cycle threshold) for further analysis. The RNA-fold change was then calculated using the comparative 2(−ΔΔCT) method73, normalized to Gapdh.
Protein expression profile by immunohistochemistry
Floating immunohistochemistry procedures were performed to precisely localize protein expression in the different chemosensory epithelia31,32. Accordingly, and prior to tissue isolation, mouse heads were chemically fixated in 4% paraformaldehyde (PAF 4%, pH 7.4). After 24 h of fixation, chemosensory epithelia were rinsed in PBS and included in low melting 4% agar. Serial coronal slices of 80–120 μm were generated with a vibroslicer (VT1200S; Leica) and collected in ice-cold PBS. Slices were then selected under a stereomicroscope (M165 FC; Leica) based on their general morphology and/or GFP expression. Selected slices were then blocked for 3 h at room temperature in a PBS solution containing 5% normal donkey serum (NDS; Jackson ImmunoResearch) and 1% of non-ionic detergent (Triton® X-100; Fluka). A double and indirect immunostaining approach using specific primary antibodies was then used to simultaneously localize ACE2 expression with other marker proteins14,15. The primary antibodies used were directed against ACE2 (Goat anti-ACE2; PA5-47488; Invitrogen; 1:40), TMPRSS2 (Rabbit anti-TMPRSS2; ab109131; Abcam; 1:200), CK18 (Rabbit anti-CK18; PA5-14263; Invitrogen; 1:50), CK5 (Rabbit anti-CK5; ab52635; Abcam; 1:160), SOX2 (Rabbit anti-SOX2; PA1-094; Invitrogen; 1:200), GUST (Rabbit anti-Gα gust; sc-395; Santa Cruz Biotechnology; 1:250), CNGA2 (Rabbit anti-CNGA2; APC-045; Alomone Laboratories; 1:200), S100B (Rabbit anti-S100β; ab41548; Abcam; 1:500), pGCG (Rabbit anti-PGCG; PGCG-701AP; FabGennix; 1:250) and γTUB (Rabbit anti-gamma Tubulin; ab179503; Abcam; 1:250). Detection of primary antibodies was performed using fluorochrome-conjugated secondary antibodies against goat (Alexa Fluor Plus 647-conjugated, donkey anti-Goat; A32849; Invitrogen; 1:200) and rabbit (Cy3-conjugated, donkey anti-Rabbit; 711-165-152; Jackson ImmunoResearch; 1:200). Slices were then rinsed in 1% NDS solution; nuclei were counterstained with DAPI thanks to the antifade mounting medium (Vectashield®; H-1200; Vector Labs). Control experiments were performed by omitting primary antibodies and ran in parallel on C57BL/6 mice. Observations were made by LED-fluorescence microscopy (EVOS M5000; Invitrogen) and acquisitions performed with confocal microscopy (SP5; Leica). Maximum projections, reconstructions and colocalization analysis were made with computer assistance (IMARIS 6.3; Bitplane).
Protein expression profile by western-blot
Samples for western-blot analysis73 were generated with chemosensory epithelia obtained from 2 to 6 mice (with a comparable sex ratio). Protein extractions were homogenized in RIPA lysis buffer (Tris 50 mM pH 7.2, NaCl 150 mM, NP40 1%, SDS 0.1%, Na-deoxycholate 0.5%) implemented with proteases inhibitor (Pepstatine A, Aprotinin, Leupeptin hemisulfate, PMSF; Merck) and a phosphatase inhibitor cocktail (ThermoFisher Scientific) under high-speed tissue disruption (TissueLyser II; Qiagen). After centrifugation, the supernatants were collected and total protein concentration were assessed according to BCA protein assay kit (Pierce BCA Protein Assay Kit; Thermo Scientific). Then, 25 μg of proteins of each sample were separated on a 10% Tris-acetate gel and electrophoretically transferred to membranes (Amersham Protran 0.2 µm NC; GE Healthcare Life science). Membranes were then incubated with the primary antibody against ACE2 (Goat anti-ACE2; PA5-47488; Invitrogen; 1:500) or ACTIN (Rabbit anti-Actin; A2066; Merck; 1:2500). Appropriate Horseradish Peroxidase-conjugated secondary antibodies were used (Donkey anti-goat, 705-035-003, Jackson ImmunoResearch, 1:4000; Goat anti-rabbit, 111-035-003, Jackson ImmunoResearch, 1:10000) and detected by chemiluminescence (SuperSignal West Pico PLUS Chemiluminescent Substrate; Thermo Scientific) and subsequently acquired (FusionSolo; Viber). The western-blot semi-quantitative analysis of ACE2 was calculated according to the intensities detected under the curves72 (ImageJ; 1.53a) relatively expressed to ACTIN.
Statistics and reproducibility
Statistical analysis, bar graphs, and their corresponding aligned dot plots were computed with GraphPad Prism 8.4.3. Values of independent experiments from distinct samples are expressed as mean ± standard error of the mean (SEM). Sample size was determined on the basis of pilot experiments and according to previously reported publications done in the field. For histological experiments, the observed variability between individual acquisitions, at a given age, was modest and a minimum standard of a triplicate was thus necessary. Comparisons were unpaired and performed with the two-tailed Student’s t-tests with Welch’s correction in the case of non-respect of the homoscedasticity (Fisher F-tests). Mann–Whitney tests were applied in absence of Normality (Shapiro–Wilk test). Significance levels are indicated as follows for: *p < 0.05; **p < 0.01; ***p < 0.001; ns for nonsignificant.
Reporting summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
All data and materials used in the analysis are available in the main text, in the Supplementary Information and in the Supplementary Data 1 file.
References
Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med 382, 1708–1720, https://doi.org/10.1056/NEJMoa2002032 (2020).
Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273, https://doi.org/10.1038/s41586-020-2012-7 (2020).
Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506, https://doi.org/10.1016/S0140-6736(20)30183-5 (2020).
Wolfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465–469, https://doi.org/10.1038/s41586-020-2196-x (2020).
Menni, C. et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat. Med 26, 1037–1040, https://doi.org/10.1038/s41591-020-0916-2 (2020).
Spinato, G. et al. Alterations in smell or taste in mildly symptomatic outpatients With SARS-CoV-2 infection. JAMA 323, 2089–2090, https://doi.org/10.1001/jama.2020.6771 (2020).
Hannum, M. E. et al. Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19-positive patients compared to subjective methods: a systematic review and meta-analysis. Chem. senses 45, 865–874, https://doi.org/10.1093/chemse/bjaa064 (2020).
Pierron, D. et al. Smell and taste changes are early indicators of the COVID-19 pandemic and political decision effectiveness. Nat. Commun. 11, 5152, https://doi.org/10.1038/s41467-020-18963-y (2020).
Aschwanden, C. Five reasons why COVID herd immunity is probably impossible. Nature 591, 520–522, https://doi.org/10.1038/d41586-021-00728-2 (2021).
Marshall, M. COVID’s toll on smell and taste: what scientists do and don’t know. Nature 589, 342–343, https://doi.org/10.1038/d41586-021-00055-6 (2021).
Bertram, S. et al. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J. Virol. 85, 13363–13372, https://doi.org/10.1128/JVI.05300-11 (2011).
Bertram, S. et al. Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PloS one 7, e35876, https://doi.org/10.1371/journal.pone.0035876 (2012).
Hoffmann, M. et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181, 271–280 e278, https://doi.org/10.1016/j.cell.2020.02.052 (2020).
Brann, D. H. et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. 6, https://doi.org/10.1126/sciadv.abc5801 (2020).
Fodoulian, L. et al. SARS-CoV-2 receptors and entry genes are expressed in the human olfactory neuroepithelium and brain. iScience 23, 101839, https://doi.org/10.1016/j.isci.2020.101839 (2020).
Chen, M. et al. Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication. Eur. Respir. J. 56, https://doi.org/10.1183/13993003.01948-2020 (2020).
Wang, Z. et al. SARS-CoV-2 receptor ACE2 is enriched in a subpopulation of mouse tongue epithelial cells in nongustatory papillae but not in taste buds or embryonic oral epithelium. ACS Pharm. Transl. Sci. 3, 749–758, https://doi.org/10.1021/acsptsci.0c00062 (2020).
Klingenstein, M. et al. Evidence of SARS-CoV2 entry protein ACE2 in the human nose and olfactory bulb. Cells, Tissues, Organs, 1–10, https://doi.org/10.1159/000513040 (2021).
Sia, S. F. et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature 583, 834–838, https://doi.org/10.1038/s41586-020-2342-5 (2020).
Meinhardt, J. et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 24, 168–175, https://doi.org/10.1038/s41593-020-00758-5 (2021).
Bryche, B. et al. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain Behav. Immun. 89, 579–586, https://doi.org/10.1016/j.bbi.2020.06.032 (2020).
Cazzolla, A. P. et al. Taste and smell disorders in COVID-19 patients: role of interleukin-6. ACS Chem. Neurosci. 11, 2774–2781, https://doi.org/10.1021/acschemneuro.0c00447 (2020).
Glezer, I., Bruni-Cardoso, A., Schechtman, D. & Malnic, B. Viral infection and smell loss: the case of COVID-19. J. Neurochem. https://doi.org/10.1111/jnc.15197 (2020).
Merad, M. & Martin, J. C. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat. Rev. Immunol. 20, 355–362, https://doi.org/10.1038/s41577-020-0331-4 (2020).
Lewis, D. COVID-19 rarely spreads through surfaces. So why are we still deep cleaning? Nature 590, 26–28, https://doi.org/10.1038/d41586-021-00251-4 (2021).
Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215–220, https://doi.org/10.1038/s41586-020-2180-5 (2020).
Shang, J. et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 221–224, https://doi.org/10.1038/s41586-020-2179-y (2020).
Firestein, S. How the olfactory system makes sense of scents. Nature 413, 211–218, https://doi.org/10.1038/35093026 (2001).
Mombaerts, P. Genes and ligands for odorant, vomeronasal and taste receptors. Nat. Rev. Neurosci. 5, 263–278, https://doi.org/10.1038/nrn1365 (2004).
Munger, S. D., Leinders-Zufall, T. & Zufall, F. Subsystem organization of the mammalian sense of smell. Annu. Rev. Physiol. 71, 115–140, https://doi.org/10.1146/annurev.physiol.70.113006.100608 (2009).
Brechbühl, J., de Valliere, A., Wood, D., Nenniger Tosato, M. & Broillet, M. C. The Grueneberg ganglion controls odor-driven food choices in mice under threat. Commun. Biol. 3, 533, https://doi.org/10.1038/s42003-020-01257-w (2020).
Moine, F., Brechbühl, J., Nenniger Tosato, M., Beaumann, M. & Broillet, M. C. Alarm pheromone and kairomone detection via bitter taste receptors in the mouse Grueneberg ganglion. BMC Biol. 16, 12, https://doi.org/10.1186/s12915-017-0479-y (2018).
Brechbühl, J. et al. Morphological and physiological species-dependent characteristics of the rodent Grueneberg ganglion. Front. Neuroanat. 8, https://doi.org/10.3389/fnana.2014.00087 (2014).
Brechbühl, J. et al. Mouse alarm pheromone shares structural similarity with predator scents. Proc. Natl Acad. Sci. USA 110, 4762–4767, https://doi.org/10.1073/pnas.1214249110 (2013).
Brechbühl, J., Klaey, M. & Broillet, M. C. Grueneberg ganglion cells mediate alarm pheromone detection in mice. Science 321, 1092–1095, https://doi.org/10.1126/science.1160770 (2008).
Chao, Y. C., Fleischer, J. & Yang, R. B. Guanylyl cyclase-G is an alarm pheromone receptor in mice. EMBO J. 37, 39–49, https://doi.org/10.15252/embj.201797155 (2018).
Margolis, F. L. A brain protein unique to the olfactory bulb. Proc. Natl Acad. Sci. USA 69, 1221–1224, https://doi.org/10.1073/pnas.69.5.1221 (1972).
Mombaerts, P. et al. Visualizing an olfactory sensory map. Cell 87, 675–686, https://doi.org/10.1016/S0092-8674(00)81387-2 (1996).
Potter, S. M. et al. Structure and emergence of specific olfactory glomeruli in the mouse. J. Neurosci. 21, 9713–9723, https://doi.org/10.1523/JNEUROSCI.21-24-09713.2001 (2001).
Fletcher, R. B. et al. Deconstructing olfactory stem cell trajectories at single-cell resolution. Cell Stem Cell 20, 817–830 e818, https://doi.org/10.1016/j.stem.2017.04.003 (2017).
Lin, B. et al. Injury induces endogenous reprogramming and dedifferentiation of neuronal progenitors to multipotency. Cell Stem Cell 21, 761–774 e765, https://doi.org/10.1016/j.stem.2017.09.008 (2017).
Sakaguchi, W. et al. Existence of SARS-CoV-2 entry molecules in the oral cavity. Int. J. Mol. Sci. 21, https://doi.org/10.3390/ijms21176000 (2020).
Zhang, C. et al. Keratin 18 is associated with a subset of older taste cells in the rat. Differentiation 59, 155–162, https://doi.org/10.1046/j.1432-0436.1995.5930155.x (1995).
Brechbühl, J., Moine, F. & Broillet, M. C. Mouse Grueneberg ganglion neurons share molecular and functional features with C. elegans amphid neurons. Front Behav. Neurosci. 7, 193, https://doi.org/10.3389/fnbeh.2013.00193 (2013).
Winkler, E. S. et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat. Immunol. 21, 1327–1335, https://doi.org/10.1038/s41590-020-0778-2 (2020).
Roppolo, D., Ribaud, V., Jungo, V. P., Luscher, C. & Rodriguez, I. Projection of the Grüneberg ganglion to the mouse olfactory bulb. Eur. J. Neurosci. 23, 2887–2894, https://doi.org/10.1111/j.1460-9568.2006.04818.x (2006).
Bilinska, K., Jakubowska, P., Von Bartheld, C. S. & Butowt, R. Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: identification of cell types and trends with age. ACS Chem. Neurosci. 11, 1555–1562, https://doi.org/10.1021/acschemneuro.0c00210 (2020).
Lingappan, K., Karmouty-Quintana, H., Davies, J., Akkanti, B. & Harting, M. T. Understanding the age divide in COVID-19: why are children overwhelmingly spared? Am. J. Physiol. Lung Cell Mol. Physiol. 319, L39–L44, https://doi.org/10.1152/ajplung.00183.2020 (2020).
Yee, M., David Cohen, E., Haak, J., Dylag, A. M. & O’Reilly, M. A. Neonatal hyperoxia enhances age-dependent expression of SARS-CoV-2 receptors in mice. Sci. Rep. 10, 22401, https://doi.org/10.1038/s41598-020-79595-2 (2020).
Steinman, J. B., Lum, F. M., Ho, P. P., Kaminski, N. & Steinman, L. Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics. Proc. Natl Acad. Sci. USA 117, 24620–24626, https://doi.org/10.1073/pnas.2012358117 (2020).
Riera, C. E. et al. The sense of smell impacts metabolic health and obesity. Cell Metab. 26, 198–211 e195, https://doi.org/10.1016/j.cmet.2017.06.015 (2017).
Rochet, M., El-Hage, W., Richa, S., Kazour, F. & Atanasova, B. Depression, olfaction, and quality of life: a mutual relationship. Brain Sci. 8, https://doi.org/10.3390/brainsci8050080 (2018).
Gentzsch, M. & Rossier, B. C. A pathophysiological model for COVID-19: critical importance of transepithelial sodium transport upon airway infection. Function 1, zqaa024, https://doi.org/10.1093/function/zqaa024 (2020).
Muus, C. et al. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Nat Med. https://doi.org/10.1038/s41591-020-01227-z (2021).
Nguyen, N. N., Hoang, V. T., Lagier, J. C., Raoult, D. & Gautret, P. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Clin. Microbiol. Infect, https://doi.org/10.1016/j.cmi.2020.12.021 (2021).
Somekh, I., Yakub Hanna, H., Heller, E., Bibi, H. & Somekh, E. Age-dependent sensory impairment in COVID-19 infection and its correlation with ACE2 expression. Pediatr. Infect. Dis. J. 39, e270–e272, https://doi.org/10.1097/INF.0000000000002817 (2020).
Bao, L. et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature 583, 830–833, https://doi.org/10.1038/s41586-020-2312-y (2020).
Dinnon, K. H. 3rd et al. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature 586, 560–566, https://doi.org/10.1038/s41586-020-2708-8 (2020).
Munoz-Fontela, C. et al. Animal models for COVID-19. Nature 586, 509–515, https://doi.org/10.1038/s41586-020-2787-6 (2020).
Sun, S. H. et al. A mouse model of SARS-CoV-2 infection and pathogenesis. Cell Host Microbe 28, 124–133 e124, https://doi.org/10.1016/j.chom.2020.05.020 (2020).
de Melo, G. D. et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. https://doi.org/10.1126/scitranslmed.abf8396 (2021).
Shigemura, N. et al. Expression of renin-angiotensin system components in the taste organ of mice. Nutrients 11, https://doi.org/10.3390/nu11092251 (2019).
Lee, I. T. et al. ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs. Nat. Commun. 11, 5453, https://doi.org/10.1038/s41467-020-19145-6 (2020).
Ziegler, C. G. K. et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181, 1016–1035 e1019, https://doi.org/10.1016/j.cell.2020.04.035 (2020).
Rosa, B. A. et al. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. Commun. Biol. 4, 290, https://doi.org/10.1038/s42003-021-01829-4 (2021).
Zimmermann, P. & Curtis, N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch. Dis. Child. https://doi.org/10.1136/archdischild-2020-320338 (2020).
de Vries, R. D. et al. Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets. Science https://doi.org/10.1126/science.abf4896 (2021).
Hassan, A. O. et al. A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2. Cell 183, 169–184 e113, https://doi.org/10.1016/j.cell.2020.08.026 (2020).
Daly, J. L. et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370, 861–865, https://doi.org/10.1126/science.abd3072 (2020).
Cantuti-Castelvetri, L. et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370, 856–860, https://doi.org/10.1126/science.abd2985 (2020).
Matsuo, T., Rossier, D. A., Kan, C. & Rodriguez, I. The wiring of Grueneberg ganglion axons is dependent on neuropilin 1. Development 139, 2783–2791, https://doi.org/10.1242/dev.077008 (2012).
Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675, https://doi.org/10.1038/nmeth.2089 (2012).
Auberson, M. et al. SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney. Pflug. Arch. 470, 1739–1751, https://doi.org/10.1007/s00424-018-2190-4 (2018).
Acknowledgements
We thank M. Auberson, F. Durussel for biochemistry advices and E. Corset for technical support; B. Rossier for his thoughtful discussions on the manuscript. This work was supported by the Department of Biomedical Sciences, University of Lausanne, and by the Swiss National Science Foundation Grant 310030_185161 (to M.-C.B.).
Author information
Authors and Affiliations
Contributions
J.B. and M.-C.B designed the project. J.B., A.C.L., D.W., S.B., A.dV., and C.V. carried out experimental procedures. All authors discussed the results and analyzed data. J.B. and M.-C.B. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Peer review information Communications Biology thanks the anonymous reviewers for their contribution to the peer review of this work. Primary Handling Editor: Karli Montague-Cardoso. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Brechbühl, J., Lopes, A.C., Wood, D. et al. Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms. Commun Biol 4, 880 (2021). https://doi.org/10.1038/s42003-021-02410-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s42003-021-02410-9
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.